Nephro Care India Limited (NSE SME)
Jun 28, 2024 - Jul 2, 2024
| Price | ₹85 - ₹90 |
| Premium | ₹175 |
|---|---|
| Lot size | 1600 |
| Allotment | Jul 3, 2024 |
| Listing | Jul 5, 2024 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 1600 | 144000 | 903 |
| HNI | 2 | 3200 | 288000 | 387 |
Last updated on 02-Jul-2024 17:13:02
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIB | 825600 | 202387200 | 245.14 |
| NIB | 619200 | 1106856000 | 1787.56 |
| RETAIL | 1444800 | 916177600 | 634.12 |
| Total | 2889600 | 2225420800 | 770.15 |
| Retail Apps | 572611 | © IPO Premium | |
| HNI Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹215.98 | @8% ₹246.83 | @9% ₹277.68 | @10% ₹308.54 | @11% ₹339.39 | @12% ₹370.25 |
Nephro Care India IPO Details
| Issue Size | 4,584,000 shares (aggregating up to ₹41.26 Cr) |
| Fresh Issue | 4,584,000 shares (aggregating up to ₹41.26 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 11,902,400 |
| Share holding post issue | 16,486,400 |
| Market Maker portion | 230,400 shares Ss Corporate Securities |
Nephro Care India IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Key Performance Indicator
| KPI | Dec-23 | Mar-23 | Mar-22 |
|---|---|---|---|
| ROE | 41.57% | 132.46% | -3.84% |
| ROCE | 36.56% | 71.09% | 4.13% |
| D/E | - | 1.68 | 9.95 |
| RONW | 24.42% | 79.68% | -1.98% |
| EPS (basic & diluted) | 3.36 | 1.94 | -0.03 |
| P/E (Pre IPO) | 55.15 | ||
| P/E (Post IPO) | 32.73 |
Company Financials
Nephro Care India Limited Financial Information (Restated)
Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period | Dec 2023 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|
| Assets | 2,029.85 | 831.11 | 462.93 | 112.84 |
| Revenue | 1,989.60 | 1,709.51 | 342.70 | 183.26 |
| Profit | 340.04 | 194.24 | -0.98 | 8.87 |
| Net Worth | 1,392.32 | 243.76 | 49.52 | 1.50 |
| Reserves | 1,332.81 | 193.76 | -0.48 | 0.50 |
| Borrowing | 246.39 | 253.74 | 69.27 | |
| Amount in ₹ Lakhs | ||||
About Company
Incorporated in 2014, Nephro Care India Limited is a comprehensive treatment center based in Kolkata, specializing in renal insufficiency treatments and offering a broad spectrum of clinical and lifestyle solutions. Supported by a team of expert doctors, experienced paramedical professionals, and a skilled management team, Nephro Care serves approximately 900 Chronic Kidney Disease patients monthly. The hospital employs 110 staff members, including 5 permanent doctors, 10 visiting consultants, and 70 paramedical professionals, and operates from its main Salt Lake clinic, spanning 5,352 square feet, alongside three satellite clinics in Salt Lake (HB 113) and Chandannagar, West Bengal. Nephro Care provides a range of services, including an in-house Dialysis Unit, outpatient services in nephrology, diabetology, cardiology, ophthalmology, and neurology, an NABL accredited in-house pathology, an in-house pharmacy, advanced diagnostic facilities, a renal nutrition department, home care, the Mukti Lifestyle Support Program, and home dialysis.
Strength Factors
Holistic Care Approach: Nephro Care integrates modern medical science with time-tested yogic wisdom to promote overall patient wellbeing, effectively bridging the gap between day care and tertiary care services.
Advanced Technology: A robust technology backbone supports consistent improvements in the quality and efficiency of service delivery.
Proven Performance: The company has a strong track record of operational and financial performance and growth.
Risk Factors
Geographic Concentration: All clinics are located in Kolkata, and the company's revenues are significantly dependent on the flagship Salt Lake clinic, making it vulnerable to local economic or political changes.
Expansion Risks: The expansion into new business verticals, such as setting up a hospital, may expose the company to new challenges and increased risks.
Dependence on Healthcare Professionals: The company is highly dependent on its healthcare professionals, and any future inability to attract or retain such talent could adversely affect its business, financial condition, and operations.
Nephro Care India IPO Lead Manager(s)
- Corporate Capitalventures Pvt Ltd
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html